close

Agreements

Date: 2017-08-02

Type of information: Nomination

Compound:

Company: Biophytis (France)

Therapeutic area: Ageing diseases - Muscle disorders - Ophtalmological diseases

Type agreement: nomination

Action mechanism:

Disease:

Details:

  • • On August 2nd, 2017, Biophytis announced the appointment of Dr. Manfred Horst as Business Development Officer. Manfred Horst, Doctor of Medicine (Ludwig-Maximilians-Universität, Munich), PhD in allergology and an MBA graduate from INSEAD, is a seasoned pharmaceutical business development executive with more than 25 years of pharmaceutical industry experience in marketing, market access and health economics, that will benefit Biophytis’ operations.
  • Prior to joining Biophytis, Manfred Horst was Business Development Director Europe at Merck Sharp & Dohme from 2004 to 2016, where he has been fully involved in searching, negotiating and managing partnerships.

Financial terms:

Latest news:

Is general: Yes